Serum triglyceride concentrations and cancer risk in a large cohort study in Austria

British Journal of Cancer

Volumn 101, Issue 7, 2009, Pages 1202-1206

  Ulmer, H ^a   Borena, W ^a   Rapp, K ^b   Klenk, J ^b   Strasak, A ^a   Diem, G ^c   Concin, H ^c   Nagel, G ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF ULM   (Germany)

^c AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

Cancer incidence; Epidemiology; STGs

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; AUSTRIA; BODY MASS; CANCER REGISTRY; CANCER RISK; ENDOMETRIUM CANCER; FEMALE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; THYROID CANCER; TRIACYLGLYCEROL BLOOD LEVEL; UTERINE CERVIX CANCER;

ADULT; AGED; COHORT STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSTATIC NEOPLASMS; RISK; TRIGLYCERIDES;

EID: 70349682420     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605264     Document Type: Article

References (52)

1. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2009) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (E-pub ahead of print 8 April 2009)
2. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107: 28-36 (Pubitemid 43941640)
3. Ashley Jr FW, Kannel WB (1974) Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis 27: 103-114
4. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3: 565-574
5. Bird CL, Ingles SA, Frankl HD, Lee ER, Longnecker MP, Haile RW (1996) Serum lipids and adenomas of the left colon and rectum. Cancer Epidemiol Biomarkers Prev 5: 607-612
6. Brunzell JD (2007) Clinical practice. Hypertriglyceridemia. N Engl J Med 357: 1009-1017
7. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591
8. Cartmel B, Dziura J, Cullen MR, Vegso S, Omenn GS, Goodman GE, Redlich CA (2005) Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). Eur J Clin Nutr 59: 1173-1180 (Pubitemid 41508665)
9. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjonneland A, Olsen A, Overvad K, Jakobsen MU, Chajes V, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Lukanova A, Boeing H, Pischon T, Trichopoulou A, Christina B, Trichopoulos D, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Gram IT, Lund E, Quiros JR, Travier N, Martinez-Garcia C, Larranaga N, Chirlaque MD, Ardanaz E, Berglund G, Lundin E, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Bingham S, Khaw KT, Allen N, Key T, Ferrari P, Rinaldi S, Slimani N, Riboli E (2007) Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14: 755-767 (Pubitemid 350074064)
10. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887
11. Esteve E, Ricart W, Fernandez-Real JM (2005) Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24: 16-31
12. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst 94: 981-990 (Pubitemid 34814727)
13. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96: 1152-1160 (Pubitemid 39207051)
14. Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Beeson WL, Buring JE, Colditz GA, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Koenig KL, Larsson SC, Leitzmann M, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Ross JA, Schatzkin A, Schouten LJ, Smit E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Smith-Warner SA (2006) A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer. Cancer Causes Control 17: 273-285 (Pubitemid 43261891)
15. Gotto Jr AM (1998) Triglyceride: the forgotten risk factor. Circulation 97: 1027-1028
16. Hinds MW, Kolonel LN, Lee J, Hankin JH (1983) Dietary cholesterol and lung cancer risk among men in Hawaii. Am J Clin Nutr 37: 192-193 (Pubitemid 13130689)
17. Kahn HS, Valdez R (2003) Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr 78: 928-934
18. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45: 1169-1196 (Pubitemid 38802622)
19. Kono S, Ikeda N, Yanai F, Yamamoto M, Shigematsu T (1990) Serum lipids and colorectal adenoma among male self-defence officials in northern Kyushu, Japan. Int J Epidemiol 19: 274-278 (Pubitemid 20197563)
20. Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat Res 659: 15-30
21. Kushi L, Giovannucci E (2002) Dietary fat and cancer. Am J Med 113(Suppl 9B): 63S-70S
22. Langsted A, Freiberg JJ, Nordestgaard BG (2008) Fasting and nonfasting lipid levels. Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118(20): 2047-2056
23. Lim U, Gayles T, Katki HA, Stolzenberg-Solomon R, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2007) Serum high-density lipoprotein cholesterol and risk of non-Hodgkin's lymphoma. Cancer Res 67: 5569-5574 (Pubitemid 46997300)
24. Lund HL, Wisloff TF, Holme I, Nafstad P (2006) Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 164: 769-774 (Pubitemid 44522081)
25. McKeown-Eyssen G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3: 687-695
26. Oberaigner W, Vittadello F (2006) Cancer mapping in Alpine Regions 1996-2000. Pro literature Verlag: Mammendarf
27. Otani T, Iwasaki M, Ikeda S, Kozu T, Saito H, Mutoh M, Wakabayashi K, Tsugane S (2006) Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan). Cancer Causes Control 17: 1245-1252 (Pubitemid 44772824)
28. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, all at the International Agency for Research on Cancer (2003) Cancer Incidence in Five Continents. IARC: Lyon, France
29. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2005) Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria. Br J Cancer 93: 1062-1067 (Pubitemid 41548403)
30. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2006) Fasting blood glucose and cancer risk in a cohort of more than 140 000 adults in Austria. Diabetologia 49: 945-952
31. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578 (Pubitemid 351232031)
32. Rose G, Shipley MJ (1980) Plasma lipids and mortality: a source of error. Lancet 1: 523-526 (Pubitemid 10176630)
33. Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, Pettinger M, Robinson J, Hendrix S, Hsia J (2008) Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med 168: 2245-2253
34. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V (2007) Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 Western prospective studies. Circulation 115: 450-458 (Pubitemid 46184196)
35. Sattler AM, Soufi M, Maisch B, Schaefer JR (2005) Lipids and lipoproteins in women. Herz 30: 368-374
36. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ (2003) Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12: 412-418 (Pubitemid 36578478)
37. Sowers MR, Randolph Jr J, Jannausch M, Lasley B, Jackson E, McConnell D (2008) Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the 'timing hypothesis'. Arch Intern Med 168: 2146-2153
38. Strasak AM, Pfeiffer RM, Brant LJ, Rapp K, Hilbe W, Oberaigner W, Lang S, Borena W, Concin H, Diem G, Ruttmann E, Glodny B, Pfeiffer KP, Ulmer H (2009) Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study. Ann Oncol 20(6): 1113-1120
39. Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, Concin H, Diem G, Pfeiffer KP, Ruttmann E, Ulmer H (2008a) Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer 123: 1902-1906
40. Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H (2008b) Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 68: 3970-3977 (Pubitemid 351302628)
41. Tabuchi M, Kitayama J, Nagawa H (2006) Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol 12: 1261-1264
42. Tabuchi M, Kitayama J, Nagawa H (2008) Hyperglycemia and hypertriglyceridemia may associate with the adenoma-carcinoma transition in colorectal epithelial cells. J Gastroenterol Hepatol 23: 985-987 (Pubitemid 351806568)
43. Tande AJ, Platz EA, Folsom AR (2006) The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 164: 1094-1102 (Pubitemid 44851745)
44. Tsushima M, Nomura AM, Lee J, Stemmermann GN (2005) Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 50: 499-505 (Pubitemid 40543738)
45. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22 946 Icelanders. Cancer Epidemiol Biomarkers Prev 6: 863-873 (Pubitemid 27481633)
46. Ulmer H, Kelleher C, Diem G, Concin H (2004) Why Eve is not Adam: prospective follow-up in 149 650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health (Larchmt) 13: 41-53 (Pubitemid 38312684)
47. Vatten LJ, Foss OP (1990) Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24 329 Norwegian women. Cancer Res 50: 2341-2346 (Pubitemid 20134492)
48. Whitehead TP, Clarke CA, Whitfield AG (1978) Biochemical and haematological markers of alcohol intake. Lancet 1: 978-981 (Pubitemid 8337725)
49. World Health Organisation (1998) Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. WHO: Geneva
50. World Health Organization (2008) International Classification of Diseases (ICD). WHO: Geneva. Available at http://www.who.int/classifications/icd/en
51. Wuermli L, Joerger M, Henz S, Schmid HP, Riesen WF, Thomas G, Krek W, Cerny T, Gillessen S (2005) Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis 8: 316-320
52. Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H, Kono S (1998) Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27: 794-798 (Pubitemid 28504966)